This hypothesis is supported by our observation that H3C14 overexpression reduces both GCB resistance and tumour aggressiveness, suggesting that its excretion via Excretion‐EVs may represent an adaptive strategy of GCB‐resistant cells to maintain their survival and aggressiveness. The gene discussed is H3C14; the disease is neoplasm.